CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 34 filers reported holding CONMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $332,297 | -23.1% | 286,000 | +2.9% | 0.02% | -26.5% |
Q2 2023 | $431,995 | -88.3% | 278,000 | -90.8% | 0.03% | -87.9% |
Q1 2023 | $3,688,528 | -20.6% | 3,020,000 | -25.9% | 0.28% | -3.1% |
Q4 2022 | $4,644,575 | +38.2% | 4,076,000 | +33.1% | 0.29% | +53.7% |
Q3 2022 | $3,361,000 | -29.8% | 3,063,000 | -22.9% | 0.19% | -35.2% |
Q2 2022 | $4,789,000 | -53.3% | 3,972,000 | -34.7% | 0.29% | -77.6% |
Q1 2022 | $10,261,000 | +0.2% | 6,082,000 | -2.8% | 1.29% | +85.7% |
Q4 2021 | $10,245,000 | -32.2% | 6,259,000 | -36.4% | 0.70% | -39.7% |
Q3 2021 | $15,118,000 | -1.6% | 9,836,000 | +4.7% | 1.16% | -17.4% |
Q2 2021 | $15,357,000 | -3.1% | 9,398,000 | -6.4% | 1.40% | -24.3% |
Q1 2021 | $15,854,000 | +5.6% | 10,045,000 | -5.1% | 1.85% | +18.1% |
Q4 2020 | $15,014,000 | +32.0% | 10,584,000 | +5.5% | 1.57% | +16.4% |
Q3 2020 | $11,377,000 | +73.8% | 10,031,000 | +63.7% | 1.34% | +43.5% |
Q2 2020 | $6,546,000 | +17.9% | 6,126,000 | +3.7% | 0.94% | +12.9% |
Q1 2020 | $5,553,000 | – | 5,907,000 | – | 0.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mohican Financial Management, LLC | 2,840,000 | $3,958,000 | 4.02% |
ZAZOVE ASSOCIATES LLC | 13,564,000 | $18,956,000 | 2.33% |
SHENKMAN CAPITAL MANAGEMENT INC | 10,584,000 | $15,014,000 | 1.57% |
SSI INVESTMENT MANAGEMENT LLC | 8,349,000 | $11,673,000 | 0.83% |
OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $12,528,000 | 0.75% |
MACKAY SHIELDS LLC | 32,384,000 | $45,397,000 | 0.31% |
ADVENT CAPITAL MANAGEMENT /DE/ | 8,379,000 | $11,734,000 | 0.25% |
PALISADE CAPITAL MANAGEMENT, LP | 5,271,000 | $7,387,000 | 0.19% |
Calamos Advisors LLC | 23,007,000 | $32,262,000 | 0.19% |
WESTWOOD HOLDINGS GROUP INC | 10,200,000 | $14,415,000 | 0.17% |